Literature DB >> 10483994

Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis.

G D Eslick1, L L Lim, J E Byles, H H Xia, N J Talley.   

Abstract

OBJECTIVE: As conflicting studies have recently been published, we aimed to determine if Helicobacter pylori (H. pylori) infection is associated with gastric adenocarcinoma.
METHODS: This was a meta-analysis of observational epidemiological studies.
RESULTS: A total of 42 studies met the selection criteria and were categorized by the type of study design: eight cohort and 34 case-control studies. The pooled odds ratio for H. pylori in relation to gastric carcinoma was 2.04 (95% CI: 1.69-2.45). Both patient age (OR 0.77, 95% CI: 0.68-0.89) and intestinal type cancers (OR 1.14, 95% CI: 1.05-1.25) were independent effect modifiers. Analysis of other effect modifiers showed no relationship with female gender (OR 0.76, 95% CI: 0.64-0.89), stage of cancer (advanced %) (OR 1.12, 95% CI: 0.88-1.43), anatomical location (cardia %) (OR 1.54, 95% CI: 0.32-7.39) or cohort (nested case-control) studies (OR 1.72, 95% CI: 0.32-9.17). There was significant heterogeneity among the studies (tau2 = 149; p < 0.001). The quality of the studies varied considerably, with the majority of excellent studies producing positive results and the very poor to moderate studies producing mixed results.
CONCLUSIONS: H. pylori infection is associated with a 2-fold increased risk of developing gastric adenocarcinoma.

Entities:  

Mesh:

Year:  1999        PMID: 10483994     DOI: 10.1111/j.1572-0241.1999.01360.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  105 in total

Review 1.  Helicobacter pylori infection transmitted sexually via oral-genital contact: a hypothetical model.

Authors:  G D Eslick
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

2.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

3.  Assessing the risks and benefits of treating Helicobacter pylori infection.

Authors:  Ivan F N Hung; Benjamin C Y Wong
Journal:  Therap Adv Gastroenterol       Date:  2009-05       Impact factor: 4.409

4.  Combined effect of miR-146a rs2910164 G/C polymorphism and Toll-like receptor 4 +3725 G/C polymorphism on the risk of severe gastric atrophy in Japanese.

Authors:  Asahi Hishida; Keitaro Matsuo; Yasuyuki Goto; Mariko Naito; Kenji Wakai; Kazuo Tajima; Nobuyuki Hamajima
Journal:  Dig Dis Sci       Date:  2010-08-19       Impact factor: 3.199

Review 5.  Synchronous and metachronous occurrence of gastric adenocarcinoma and gastric lymphoma: A review of the literature.

Authors:  Erhan Hamaloglu; Serdar Topaloglu; Arif Ozdemir; Ahmet Ozenc
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

6.  Helicobacter pylori seroprevalence in patients with lung cancer.

Authors:  Nikiphoros Philippou; Panagiotis Koursarakos; Evgenia Anastasakou; Vasiliki Krietsepi; Stavroula Mavrea; Anastasios Roussos; Dionissia Alepopoulou; Irineos Iliopoulos
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 7.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

8.  Is gastroscopy for fecal immunochemical test positive patients worthwhile?

Authors:  Jing Yu Ng; Dedrick Kok Hong Chan; Ker Kan Tan
Journal:  Int J Colorectal Dis       Date:  2016-09-30       Impact factor: 2.571

9.  Upper gastrointestinal diseases in patients for endoscopy in South-Western Uganda.

Authors:  Siraji Obayo; Conrad Muzoora; Ponsiano Ocama; Matthew M Cooney; Tony Wilson; Christopher S Probert
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

10.  Discovering differential protein expression caused by CagA-induced ERK pathway activation in AGS cells using the SELDI-ProteinChip platform.

Authors:  Zhen Ge; Yong-Liang Zhu; Xian Zhong; Jie-Kai Yu; Shu Zheng
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.